effect overlay
activetrials

Retrospective analyses of clinically acquired MRI in multiple sclerosis
 

HREC: 2017.118
Principal Investigator: Prof Helmut Butzkueven
Coordinator contact: Dr Ai-Lan Nguyen
Funding: Non-Commercial
Multiple Sclerosis

Assessment of whether Cladribine reconfigures mononuclear cells to a reparative M2-like phenotype
 

HREC: 2018.197
Principal Investigator: Prof Trevor Kilpatrick
Coordinator contact: Katherine Fazzolari
Funding: Non-Commercial
Multiple Sclerosis

A Phase IIIb Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis
 

HREC: 2019.072
Principal Investigator: Dr Chris Dwyer
Coordinator contact: Hasini Fernando
Funding: Commercial
Multiple Sclerosis

Role of free circulating mitochondria in the pathogenesis of Multiple Sclerosis
 

HREC: 2019.111
Principal Investigator: Dr Mastura Monif
Coordinator contact: Dr Mastura Monif
Funding: Non-Commercial
Multiple Sclerosis

Autoimmune encephalitis and other neuroinflammatory conditions
 

HREC: 2019.140
Principal Investigator: Dr Mastura Monif
Coordinator contact:
Funding: Non-Commercial